(Q52291172)

English

A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers.

scientific article published in May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

author name string

Elbert D Glover

1

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Molly T Laflin

2

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Kory J Schuh

3

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Leslie M Schuh

4

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Mitch Nides

5

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Arden G Christen

6

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Penny N Glover

7

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Julia V Strnad

8

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

language of work or name

0 references

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

102

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

5

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

795-802

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2007.01763.X

21 January 2018

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2007.01763.X

21 January 2018

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2007.01763.X

21 January 2018

Mecamylamine does not precipitate withdrawal in cigarette smokers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2007.01763.X

21 January 2018

Identifiers

10.1111/J.1360-0443.2007.01763.X

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/17506156

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52291172&oldid=1023195113"